abstract |
The present invention features a polyvalent vaccine for inducing an immune response and methods for treating patients with melanoma or preventing the recurrence of melanoma in patients in need. The vaccine can also be administered in combination with one or more active pharmaceutical ingredients, such as one or more checkpoint inhibitors. Also provided are methods for using and making the compositions. |